Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Royal Oak › NPI 1104277045
Lab

RPPC Labs, LLC

RPPC Labs, LLC was paid $1K by Medicaid between Mar 2018 and Mar 2018, across 1 billing code. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 100% of everything it billed.

33Billing provider infoRPPC LABS, LLC
ROYAL OAK, MI 48067
33aNPI1104277045assigned 06/22/2016
28Total paid$1K
24GClaims12
24DCodes billed1
24AFirst – last monthMar 2018 – Mar 2018
Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#100 of 108
Median peer was paid$588K
This provider vs. median0.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500$1.0K$1.5K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201812$1K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 100% 12 12 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEVY, CAMILLE (DIRECTOR OF REVENUE CYCLE MANAGEMEN)
Same official

Other billing entities under LEVY, CAMILLE

Full network →
ProviderLocationPaid
Rehabilitation Physicians PCNovi, MI$3.21M
Rppcpt PLLCNovi, MI$150K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.